Preparing Children for Travel in Asia

Waasdorp, Christine E.; Kim, Ji Yeon

doi:10.1580/06-weme-ra-026r2.1

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The WHO report of the year 2007 had highlighted DF a great threat for travelers (17). The appropriate education to the travelers can be helpful to reduce arthropod borne diseases (18).…”

Section: Predisposing Factorsmentioning

confidence: 99%

Dengue Viral Infection and Necessity for Screening Patients Having Pyrexia of Unknown Origin

Zafar¹,

Bukhari²,

Humayoun³

et al. 2017

Ulutas Med J

View full text Add to dashboard Cite

Dengue Viral Infection (DVI) is an emerging global health problem infecting about 50-100 million people annually world wide. More than 2.5 million people have dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Aedesaegypti is the principal vector for disease transmission while humans are the main reservoir. The clinical manifestations range from self limited Dengue fever (DF) to complicated and fatal outcomes, DHF and DSS. DF is prevalent in more than 100 countries of the world. More than 2.5 billion people of the World ' s population are residents of Dengue endemic area. According to one reported study the prevalence of DF in Pakistan is 29%. Similarly one study result carried out in India has shown 78% prevalence of DF. In Mexico the one published seroprevalence study showed 79.6% prevalence of DF. A review/analysis report of Gynecological and Obstetrical survey from 30 published studies has shown 64% transmission rate of DF from a mother to a child. The study results carried out in Jamaica has shown an increased in the prevalence of DF in seen in less than 1year and more than 60 years. The mortality rate with DHF is 33%. While in less than 15 year of it is 5%. This can be only reduced with early/ accurate diagnosis and the prompt management of the condition. Absence of specific vaccine and anti viral is responsible for making this infection as a global health problem. The US government has spent 15 million US dollars for the establishment and discovery of specific DF treatment. The study carried out in India has shown the median cost for treatment per patient about 432.2 US dollars. It is 4 times in case of private health sectors. The proposed review article will highlight the incidence of dengue infection in patients having PUO (pyrexia of unknown origin). It will be a guide for the clinicians to consider DVI in their list of differential diagnosis of PUO. Moreover it will be helpful in establishing the screening policies for DVI in PUO. The resultant of all of this will improve the life quality of PUO sufferers. It will be useful to reduce the increased financial burden due to PUO missed diagnosis and management in under developed countries like one of ours.

show abstract

“…The WHO report of the year 2007 had highlighted DF a great threat for travelers (17). The appropriate education to the travelers can be helpful to reduce arthropod borne diseases (18).…”

Section: Predisposing Factorsmentioning

confidence: 99%

Dengue Viral Infection and Necessity for Screening Patients Having Pyrexia of Unknown Origin

Zafar¹,

Bukhari²,

Humayoun³

et al. 2017

Ulutas Med J

View full text Add to dashboard Cite

show abstract

The Influence of Climate Change on Vector-Borne Diseases in a Wilderness Medicine Context

Mertens

2024

Wilderness & Environmental Medicine

View full text Add to dashboard Cite

The imminent climate crisis has been labeled as the biggest health threat humanity must deal with. Vector-borne disease distribution and transmission as well as the population at risk are influenced to a great degree by environmental and climactic factors affecting both the vectors themselves and the causative pathogens. Paired with an increase in worldwide travel, urbanization, and globalization, along with population displacements and migration, elucidating the effects of anthropogenic climate change on these illnesses is therefore of the essence to stave off potential negative sequelae. Outcomes on different vector-borne diseases will be diverse, but for many of them, these developments will result in a distribution shift or expansion with the possibility of (re-)introduction of vector and pathogen species in previously nonendemic areas. The consequence will be a growing likelihood for novel human, vector, and pathogen interactions with an increased risk for infection, morbidity, and mortality. Wilderness medicine professionals commonly work in close relationship to the natural environment and therefore will experience these alterations most strongly in their practice. Hence, this article attempts to bring awareness to the subject at hand in a wilderness medicine context, with a focus on malaria, the most burdensome of arthropod-borne diseases. For prevention of the potentially dire consequences on human health induced by climate change, concerted and intensified efforts to reduce the burning of fossil fuels and thus greenhouse gas emissions will be imperative on a global scale.

show abstract

Preparing Children for Travel in Asia

Cited by 2 publications

References 8 publications

Dengue Viral Infection and Necessity for Screening Patients Having Pyrexia of Unknown Origin

Dengue Viral Infection and Necessity for Screening Patients Having Pyrexia of Unknown Origin

The Influence of Climate Change on Vector-Borne Diseases in a Wilderness Medicine Context

Contact Info

Product

Resources

About